Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of telomerase via down regulation of its target gene, 17/April/2014, 7.10 am

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of telomerase via down regulation of its target gene, 17/April/2014, 7.10 am

Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression of telomerase via down regulation of its target gene, 17/April/2014, 7.10 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To cite: Boominathan, Insights into the treatment of human Prostate cancer: Bicalutamide, an Androgen receptor antagonist, suppresses the expression  of telomerase via down regulation of its target gene, 17/April/2014, 7.10 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing